Publication: Thrombosis: A major contributor to global disease burden
Issued Date
2014-01-01
Resource Type
ISSN
03406245
Other identifier(s)
2-s2.0-84908517909
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Thrombosis and Haemostasis. Vol.112, No.5 (2014), 843-852
Suggested Citation
Gary Raskob, P. Angchaisuksiri, A. N. Blanco, H. Buller, A. Gallus, B. J. Hunt, E. M. Hylek, A. Kakkar, S. V. Konstantinides, M. McCumber, Y. Ozaki, A. Wendelboe, J. I. Weitz Thrombosis: A major contributor to global disease burden. Thrombosis and Haemostasis. Vol.112, No.5 (2014), 843-852. doi:10.1160/TH14-08-0671 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/34858
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Thrombosis: A major contributor to global disease burden
Other Contributor(s)
University of Oklahoma Health Sciences Center
Mahidol University
Academia Nacional de Medicina de Buenos Aires
Academic Medical Centre, University of Amsterdam
Flinders Medical Centre
Guy's and St Thomas' NHS Foundation Trust
Boston University School of Medicine
Thrombosis Research Institute
Johannes Gutenberg Universitat Mainz
University of Yamanashi
McMaster University
Mahidol University
Academia Nacional de Medicina de Buenos Aires
Academic Medical Centre, University of Amsterdam
Flinders Medical Centre
Guy's and St Thomas' NHS Foundation Trust
Boston University School of Medicine
Thrombosis Research Institute
Johannes Gutenberg Universitat Mainz
University of Yamanashi
McMaster University
Abstract
© Schattauer 2014. Thrombosis is a common pathology underlying ischaemic heart disease, ischaemic stroke, and venous thromboembolism (VTE). The Global Burden of Disease Study 2010 (GBD 2010) documented that ischaemic heart disease and stroke collectively caused one in four deaths worldwide. GBD 2010 did not report data for VTE as a cause of death and disability. We performed a systematic review of the literature on the global disease burden due to VTE in low, middle and high income countries. Studies from Western Europe, North America, Australia, and Southern Latin America (Argentina) yielded consistent results with annual incidences ranging from 0.75 to 2.69 per 1,000 individuals in the population. The incidence increased to between 2 and 7 per 1,000 among those 70 years of age or more. Although the incidence is lower in individuals of Chinese and Korean ethnicity, their disease burden is not low because of population aging. VTE associated with hospitalisation was the leading cause of disability-adjusted-lifeyears (DALYs) lost in low and middle income countries, and second in high income countries, responsible for more DALYs lost than nosocomial pneumonia, catheter-related blood stream infections, and adverse drug events. VTE causes a major burden of disease across low, middle, and high income countries. More detailed data on the global burden of VTE should be obtained to inform policy and resource allocation in health systems, and to evaluate if improved utilisation of preventive measures will reduce the burden.